Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block… US FDA label
Use: Intra-Abdominal Infections, including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group ( B. fragilis , B. distasonis , B. ovatus , B. thetaiotaomicron… US FDA label
Kidney dosing: Metronidazole (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl 30–59 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl 15–29 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl <15 mL/min (not on dialysis)
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label). In end-stage kidney disease, peak levels of hydroxy-metronidazole were 2 times and of metronidazole acetate 5 times normal (label PK). Because metabolites accumulate in end-stage kidney disease, monitoring for metronidazole-associated adverse events is recommended (label).
- Hemodialysis (intermittent)
- Hemodialysis (4 to 8 hours) removes 40% to 65% of a dose. If dosing cannot be separated from the session, consider a supplemental dose after hemodialysis (label).
- Peritoneal dialysis
- No dose change on CAPD; a 7.5-hour peritoneal dialysis removed about 10% of a dose (label).
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Hemodialysis: yes (40% to 65% of a dose per 4- to 8-hour session, by membrane and duration). Peritoneal dialysis: little (about 10%) (label). Under 20% protein bound.
- Monitoring Neurologic symptoms (encephalopathy, cerebellar signs, seizures, peripheral or optic neuropathy, aseptic meningitis); liver function in hepatic impairment; INR with warfarin; lithium and creatinine with lithium (label).
From the Metronidazole monograph (renalcarematters.com, reviewed).
Use: Uses for the cure of most athlete's foot, jock itch and ringworm US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Vaginal suppository: 750 mg/200 mg/100 mg
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Lidocaine + Metronidazole + Miconazole as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Metronodazole + Miconazole Nitrate + Lidocaine (1 product, possible match).
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Neo-Penotran Forte-LMetronidazole + Miconazole Nitrate + Lidocaine | 750 mg/200 mg/100 mg Vaginal SuppositoryCasing Strip - PVC/PE (box of 7's) | Rx | INTERPHIL LABORATORIES, INC.Philippines | Trader: EMBIL INTERNATIONAL PHILIPPINES, INC. | DR-XY33679 | Jul 27, 2027 | |
Tri-VMetronidazole + Miconazole Nitrate + Lidocaine | 750 mg / 200 mg/ 100 mg Vaginal SuppositoryPVC Coated Polyethylene Foil x 7's Box of 7's | Rx | Bliss GVS Pharma Ltd.India | Ritemed Phils., Inc.Importer: Bliss GVS Pharma Ltd | DRP-8340-01 | Sep 14, 2028 | |
Trimic Forte LMetronidazole + Miconazole Nitrate + Lidocaine | 750 mg/200 mg/100 mg Vaginal SuppositoryPVC Coated Polyethylene Foil x 7's Box of 7's | Rx | Bliss GVS Pharma Ltd.India | Bliss GVS Pharma Ltd. | DRP-8340 | Sep 14, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .